Metabolites in Cancer

Oncogenomics is a sub field of genomics that portrays disease related qualities. It centers on genomic, epigenomic and transcript adjustments in growth. Malignancy is a hereditary malady caused by assemblage of DNA changes and epigenetic adjustments prompting uncontrolled cell multiplication and neoplasm advancement. The objective of oncogenomics is to recognize new oncogenes or tumor silencer qualities that may give new dreams into disease conclusion, expecting clinical aftereffect of developments and new focuses for malignancy treatments.

Cancer SocietiesChildren's Cancer AssociationFrench Society of Oncology PharmacyFrench Society of Oncology PharmacyBelgian Association of Oncological RadiotherapyCancer Registry BavariaEuropean Cancer Organization.

 

    Related Conference of Metabolites in Cancer

    June 10-11, 2024

    8th Global Meeting on Oncology and Radiology

    Barcelona, Spain
    July 11-12, 2024

    24th World Congress on Cancer and Diagnostics

    Vancouver, Canada
    July 18-19, 2024

    14th World Congress on Breast Cancer

    Paris, France
    September 16-17, 2024

    9th World Conference on Breast and Cervical Cancer

    London, UK
    September 19-20, 2024

    25th World Congress on Cancer Summit

    Paris, France
    November 24-25, 2024

    7th International Conference on Anti-Cancer Drugs

    Vancouver, Canada

    Metabolites in Cancer Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in